Small Cell Lung Cancer

Small cell lung cancer accounts for about 15% -20% of bronchogenic lung cancer. When diagnosed with small cell lung cancer, about 30% of patients have tumors in the localized stage, while the rest are in the extensive stage. When the tumor spreads beyond the supraclavicular area, it is called the extensive stage. Compared to other types of lung cancer, small cell lung cancer has better chemotherapy and radiotherapy efficacy. But because small cell lung cancer is likely to have spread widely by the time it is diagnosed, it is often difficult to cure.

Common Diseases

Small cell lung cancer (SCLC) accounts for 15% -20% of all lung cancers, mainly including three subtypes: lymphocyte (oat cell) type, intermediate cell type (spindle shaped, polygonal, etc.), and mixed type. There was no significant difference in prognosis among the three subtypes. Most small cell lung cancers are related to smoking, while other small cell lung cancers may be related to the environment or genetics. The clinical manifestations of SCLC are similar to non-small cell lung cancer (NSCLC), such as cough, hemoptysis, chest pain, chest tightness, asthma, etc. Compared with non-small cell lung cancer, small cell lung cancer has the characteristics of fast tumor doubling rate, high malignancy, early occurrence of widespread metastasis, and susceptibility to endocrine dysfunction syndrome. About 67% of small cell lung cancer patients are diagnosed with significant extrapulmonary metastasis, while only 33% of limited period patients have lesions limited to a single radiation field within the chest cavity.、

Principles of Treatment

Although small cell lung cancer is highly sensitive to chemotherapy and radiation therapy, most patients eventually metastasize and spread. Almost all patients with small cell lung cancer have a tendency for systemic spread during diagnosis, therefore combination chemotherapy and chest radiation therapy are the main treatment methods for this disease, with surgical resection only performed in a very small number of patients with limited duration. This type of tumor has a very poor prognosis, and systemic chemotherapy can definitely prolong survival and improve symptoms. However, as the remission period of drug resistance is usually less than one year, comprehensive treatment is the key to achieving cure.

The treatment of small cell lung cancer is a comprehensive process that includes multiple methods, depending on the severity, staging, and overall health status of the patient. Here are some common treatment methods for small cell lung cancer:

Conclusions

Small cell lung cancer is a highly invasive malignant tumor with its own biological characteristics and treatment needs. The close link with smoking also reminds us of the importance of tobacco control for prevention. The combination of immunotherapy and refined chemoradiotherapy strategies has improved the results, but the high recurrence rate also calls for new therapeutic approaches.